New Subsidies to Shield Breast Cancer Survivors From High Medicine Costs

Published on April 28, 2024

Early breast cancer survivors who are at high risk of the disease recurring will soon find the preventative medication costing as little as $7.70 (US$5). An additional 2,400 Australians who have lived through early breast cancer will have the cancer drug, abemaciclib (Verzenio), subsidised under a federal government scheme. Health Minister Mark Butler said thousands of Australian women get a life-changing breast cancer diagnosis every year. “The Albanese government is working hard to ensure each one gets the latest and the best treatment at a price they can afford,” Mr. Butler said in a news release. “This listing of Verzenio will benefit thousands of Australian women, and is yet another example of how the Albanese Government is delivering on its promise to provide cheaper medicines.”...